期刊
COLLOIDS AND SURFACES B-BIOINTERFACES
卷 173, 期 -, 页码 101-108出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2018.09.048
关键词
MoS2; Drug delivery; Targeted; Synergistic chemo-photothermal therapy
资金
- Shanghai Municipal Science and Technology Commission Project [16410723700]
- Biomedical Textile Materials 111 Project of the China Ministry of Education [B07024]
- UK-China Joint Laboratory for Therapeutic Textiles (Donghua University)
Molybdenum disulfide (MoS2) has been extensively explored for biomedical applications due to its excellent photothermal conversion ability. In this paper, we report a nanoplatform based on folic acid (FA) targeted dual-stimuli responsive MoS2 nanosheets and explore this for the treatment of FA-receptor positive human breast cancer. The nanocomposites generated had a uniform diameter (ca. 133 nm), and could be loaded with the anti-cancer drug doxorubicin (DOX) to a high capacity (151.4 mg/g). The release of DOX was greatly accelerated at pH 5.0 as compared to pH 7.4. In addition, it was found that drug release is enhanced under near infrared laser (NIR) irradiation, showing that the composites can be used as dual responsive systems, with DOX release controllable through pH or NIR irradiation. MIT assays and confocal experiments showed that the MoS2-based nanoplatform could selectively target and kill FA-positive MDA-MB-231 cells (a human breast cancer cell line). The platform also allowed the combination of chemotherapy and photothermal therapy, which led to synergistic effects superior to either monotherapy. The functionalized MoS2 nanoplatform developed in this work hence could be a potent system for targeted drug delivery and synergistic chemo-photothermal cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据